Document Overview

Vendor Assessment: Life Science Buyers Guide to Manufacturing and Supply Chain IT Outsourcing


Author: Eric Newmark
Document # HI223980
Published July, 2010
Document Type Vendor Assessment
Number of Pages      49
Number of Figures      4

Overview

This IDC Health Insights report provides a decision framework and a wide array of vendor-evaluative details on all significant vendors that provide IT outsourcing services for life science manufacturing and supply chain operations. With the global recession now in the rearview mirror, life science companies are slowly shifting their primary cost-cutting focus back toward long-term top-line growth. Manufacturing and supply chain strategy not only remains a critical component of maintaining lower costs (outsourcing, offshoring, lean initiatives, etc.) but also holds the key to reducing corporate liability, protecting brand equity (PAT, drug pedigree), and optimizing operational efficiency (via item-level serialization). Further, a large portion of achievable improvements reside in information already on hand, which is driving increased investment in data warehousing, analytics, and BI tools, to help better organize and unlock this information.

Eric Newmark, research manager with IDC Health Insights, said, "Several supply chain processes, ranging from sourcing and procurement to sales and operational planning (S&OP) and logistics all beg the need for additional streamlining, cost reduction, and optimization. To achieve these goals, life science companies are increasingly utilizing third-party outsourcing firms to augment and/or replace varying aspects of their IT responsibilities. We expect to see continued growth in spending on these services over the next 12 months."

IDC Health Insights Opinion | In This Study | Situation Overview | IT Suppliers | Future Outlook | Essential Guidance | Learn More

Our records show that you do not have access to this document.